ADMA - ADMA Biologics relaunches BIVIGAM; shares up 3% premarket August, 22 2019 08:11 AM ADMA Biologics Inc ADMA Biologics (NASDAQ:ADMA) announces the commercial relaunch and its first commercial sales of BIVIGAM.More news on: ADMA Biologics, Inc., Healthcare stocks news, Stocks on the move, Read more ...